Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up
- PMID: 17904936
- DOI: 10.1016/j.jada.2007.07.017
Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up
Abstract
Objective: To assist health professionals who counsel patients with overweight and obesity, a systematic review was undertaken to determine types of weight-loss interventions that contribute to successful outcomes and to define expected weight-loss outcomes from such interventions.
Design: A search was conducted for weight-loss-focused randomized clinical trials with >or=1-year follow-up. Eighty studies were identified and are included in the evidence table.
Outcomes measures: The primary outcomes were a measure of weight loss at 6, 12, 24, 36, and 48 months. Eight types of weight-loss interventions-diet alone, diet and exercise, exercise alone, meal replacements, very-low-energy diets, weight-loss medications (orlistat and sibutramine), and advice alone-were identified. By using simple pooling across studies, subjects mean amount of weight loss at each time point for each intervention was determined.
Statistical analyses performed: Efficacy outcomes were calculated by meta-analysis and provide support for the pooled data. Hedges' gu was combined across studies to obtain an average effect size (and confidence level).
Results: A mean weight loss of 5 to 8.5 kg (5% to 9%) was observed during the first 6 months from interventions involving a reduced-energy diet and/or weight-loss medications with weight plateaus at approximately 6 months. In studies extending to 48 months, a mean 3 to 6 kg (3% to 6%) of weight loss was maintained with none of the groups experiencing weight regain to baseline. In contrast, advice-only and exercise-alone groups experienced minimal weight loss at any time point.
Conclusions: Weight-loss interventions utilizing a reduced-energy diet and exercise are associated with moderate weight loss at 6 months. Although there is some regain of weight, weight loss can be maintained. The addition of weight-loss medications somewhat enhances weight-loss maintenance.
Comment in
-
Review: dietary interventions, with or without exercise, promote weight loss more than advice alone.Evid Based Nurs. 2008 Apr;11(2):44. doi: 10.1136/ebn.11.2.44. Evid Based Nurs. 2008. PMID: 18364414 No abstract available.
-
Review: diet interventions, with or without exercise, promote weight loss more than advice alone.Evid Based Med. 2008 Apr;13(2):41. doi: 10.1136/ebm.13.2.41. Evid Based Med. 2008. PMID: 18375694 No abstract available.
Similar articles
-
Long-term pharmacotherapy for obesity and overweight.Cochrane Database Syst Rev. 2003;(4):CD004094. doi: 10.1002/14651858.CD004094. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2004;(3):CD004094. doi: 10.1002/14651858.CD004094.pub2. PMID: 14584004 Updated. Review.
-
Comparison of orlistat and sibutramine in an obesity management program: efficacy, compliance, and weight regain after noncompliance.Eat Weight Disord. 2006 Dec;11(4):e127-32. doi: 10.1007/BF03327578. Eat Weight Disord. 2006. PMID: 17272944 Clinical Trial.
-
[Pharmacological therapy of obesity].G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. G Ital Cardiol (Rome). 2008. PMID: 18773755 Italian.
-
Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. doi: 10.3310/hta8210. Health Technol Assess. 2004. PMID: 15147610 Review.
-
Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.Endocr Res. 2004 May;30(2):159-67. doi: 10.1081/erc-200027356. Endocr Res. 2004. PMID: 15473126 Clinical Trial.
Cited by
-
Outcomes from Partner2Lose: a randomized controlled trial to evaluate 24-month weight loss in a partner-assisted intervention.BMC Public Health. 2024 Jul 20;24(1):1948. doi: 10.1186/s12889-024-19464-z. BMC Public Health. 2024. PMID: 39033273 Free PMC article. Clinical Trial.
-
The metabolic consequences of 'yo-yo' dieting are markedly influenced by genetic diversity.Int J Obes (Lond). 2024 Aug;48(8):1170-1179. doi: 10.1038/s41366-024-01542-2. Epub 2024 Jul 3. Int J Obes (Lond). 2024. PMID: 38961153 Free PMC article.
-
Effect of Sleeve Gastric Surgery on Body Weight and Hypothalamic-Pituitary Axis Hormone Levels in Patients with Polycystic Ovary Syndrome.Obes Surg. 2024 Jul;34(7):2375-2382. doi: 10.1007/s11695-024-07273-7. Epub 2024 Jun 3. Obes Surg. 2024. PMID: 38829463
-
Nutritional Considerations During Major Weight Loss Therapy: Focus on Optimal Protein and a Low-Carbohydrate Dietary Pattern.Curr Nutr Rep. 2024 May 30. doi: 10.1007/s13668-024-00548-6. Online ahead of print. Curr Nutr Rep. 2024. PMID: 38814519 Review.
-
Twice-Weekly 36-Hour Intermittent Fasting Practice Attenuates Hunger, Quadruples ß-Hydroxybutyrate, and Maintains Weight Loss: A Case Report.Cureus. 2024 Apr 10;16(4):e57979. doi: 10.7759/cureus.57979. eCollection 2024 Apr. Cureus. 2024. PMID: 38738128 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical